Tysabri is the most effective multiple sclerosis medicine available, but using it for more than two years raises a risk of progressive multifocal leukoencephalopathy, a brain infection that can be fatal, Bloomberg News reports.
Almost 60,000 MS patients are continuing the treatment into the danger zone anyway, saying that without it they’d be disabled.
